A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.
Yeo CD, Lee SH, Kim JS, Kim SJ, Kim SC, Kim YK, Kang HH, Yoon HK, Song JS, Moon HS, Kim JW, Kim KH, Shim BY, Kim CH.
Yeo CD, et al. Among authors: kim sc, kim yk, kim ch, kim sj, kim js, kim jw, kim kh.
Cancer Chemother Pharmacol. 2013 Oct;72(4):809-14. doi: 10.1007/s00280-013-2256-0. Epub 2013 Aug 6.
Cancer Chemother Pharmacol. 2013.
PMID: 23918044
Clinical Trial.